{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T07:57:02Z","timestamp":1790582222689,"version":"4.1.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.abd.2026.501442","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T11:48:57Z","timestamp":1786967337000},"page":"501442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pembrolizumab-induced psoriasis and radiation recall: a shared immune pathway unveiled"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4126-5170","authenticated-orcid":false,"given":"Macarena","family":"Nougues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8002-4234","authenticated-orcid":false,"given":"Paula Carolina","family":"Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3563-4700","authenticated-orcid":false,"given":"Luciana Laura","family":"Tirelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3801-194X","authenticated-orcid":false,"given":"Margarita","family":"Larralde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2026.501442_bib0005","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ad.2021.09.005","article-title":"Revisi\u00f3n sist\u00e9mica causada por los efectos adversos cut\u00e1neos por inhibidores de puntos de control inmunitario","volume":"113","author":"Juan-Carpena","year":"2022","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.abd.2026.501442_bib0010","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14830","article-title":"Psoriasis and psoriasiform reactions secondary to immune checkpoint inhibitors","volume":"34","author":"Cutroneo","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.abd.2026.501442_bib0015","first-page":"1","article-title":"Histopathological and immunohistochemical features of cutaneous and oral immune-related adverse events associated with PD-1 inhibitor therapy","author":"Medeiros","year":"2025","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.abd.2026.501442_bib0020","article-title":"Radiation recall dermatitis following treatment with pembrolizumab: case report and review of the literature","volume":"11","author":"Sandhu","year":"2023","journal-title":"J Investig Med High Impact Case Rep"},{"key":"10.1016\/j.abd.2026.501442_bib0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/reports7040091","article-title":"Pembrolizumab-induced recall dermatitis occurring 5 years after radiotherapy","volume":"7","author":"Cushman","year":"2024","journal-title":"Reports"},{"key":"10.1016\/j.abd.2026.501442_bib0030","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.clindermatol.2014.04.003","article-title":"Wolf's post-herpetic isotopic response: infections, tumors, and immune disorders arising on the site of healed herpetic infection","volume":"32","author":"Ruocco","year":"2014","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.abd.2026.501442_bib0035","article-title":"Wolf\u2019s isotopic response revisited","volume":"100","author":"Friedman","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.abd.2026.501442_bib0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jdcr.2024.09.027","article-title":"IL-23 inhibitor treatment of immune checkpoint inhibitor-associated psoriasis: case series and review of literature","volume":"56","author":"Bourand","year":"2025","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.abd.2026.501442_bib0045","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamadermatol.2015.1916","article-title":"Pembrolizumab cutaneous adverse events and their association with disease progression","volume":"151","author":"Sanlorenzo","year":"2015","journal-title":"JAMA Dermatol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059626001558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059626001558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T07:26:46Z","timestamp":1790580406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059626001558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0365059626001558"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2026.501442","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pembrolizumab-induced psoriasis and radiation recall: a shared immune pathway unveiled","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2026.501442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501442"}}